# Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

> **NCT04143516** · PHASE2,PHASE3 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 200 (estimated)

## Conditions studied

- Liver Metastases

## Interventions

- **DIAGNOSTIC_TEST:** [18-F]- FDG - PET
- **PROCEDURE:** Tumor ablation (TA)
- **DIAGNOSTIC_TEST:** PET/CT Scan

## Key facts

- **NCT ID:** NCT04143516
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-10-25
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04143516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04143516, "Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04143516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*